G6PD deficient red blood cell transfusion

G6PD deficient red blood cell transfusion is an investigational therapeutic intervention involving the transfusion of erythrocytes from donors with glucose-6-phosphate dehydrogenase (G6PD) deficiency. This intervention is primarily studied in the context of sickle cell disease (SCD) to evaluate how the absence of the G6PD enzyme—which is critical for protecting red blood cells from oxidative damage—affects the survival and biological performance of transfused cells within the oxidative stress environment characteristic of SCD patients. Developed and studied by the University of North Carolina, Chapel Hill, the intervention aims to determine if donor G6PD status significantly impacts post-transfusion recovery and erythrocyte lifespan, which has implications for optimizing transfusion protocols and donor selection for patients requiring chronic transfusion therapy.

Other names

G6PD Deficient Red Blood Cell TransfusionG-6PD Deficient Red Blood Cell TransfusionG 6PD Deficient Red Blood Cell TransfusionG6PD-deficient RBC transfusionG-6PD-deficient RBC transfusionG 6PD-deficient RBC transfusion